1-4 of 4
Yetunde Ogunsesan
Close
Sort by
Journal Articles

Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy

Samer Al Hadidi, Aniko Szabo, Jean Esselmann, Lindsay Hammons, Munawwar Hussain, Yetunde Ogunsesan, Nishanth Thalambedu, Fatima Khan, Jaskirat Sethi, Abhishek Janardan, Sabarinath Radhakrishnan, Sharmilan Thanendrarajan, Carolina Schinke, Binod Dhakal, Siegfried Janz, Saurabh Chhabra, Anita D'Souza, Maurizio Zangari, Frits van Rhee, Meera Mohan
Journal: Blood
Blood (2022) 140 (Supplement 1): 8038–8039.
https://doi.org/10.1182/blood-2022-168794
Published: 2022
Journal Articles

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant

Nishanth Thalambedu, Yetunde Ogunsesan, Jaskirat Sethi, Munawwar Hussain, Lakshmi Yarlagadda, Sravani Gundarlapalli, Horace J. Spencer, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Juan Carlos Rico Crescencio, Frits van Rhee, Carolina Schinke
Journal: Blood
Blood (2022) 140 (Supplement 1): 12922–12923.
https://doi.org/10.1182/blood-2022-169353
Published: 2022
Journal Articles

Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Yetunde Ogunsesan, Reid D. Landes, Jaskirat Sethi, Munawwar Hussain, Nishanth Thalambedu, Lakshmi Yarlagadda, Sravani Gundarlapalli, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Carolina Schinke
Journal: Blood
Blood (2022) 140 (Supplement 1): 10579–10580.
https://doi.org/10.1182/blood-2022-167624
Published: 2022
Journal Articles

Diagnosing Mds; Do We Really Need to FISH?

Saad Jamshed, MD, William Fricke, MD, Yetunde Ogunsesan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5436.
https://doi.org/10.1182/blood-2019-126281
Published: 2019